["{\n\"step_by_step_thinking\": \"The question is asking why capsular polysaccharides are conjugated to protein carriers like tetanus toxoid during vaccine development. The key point is that the original Hib vaccine was ineffective in stimulating an adequate immune response in children younger than two years of age, and the new Hib conjugate vaccines provide superior efficacy and immunogenicity compared with the original unconjugated vaccine. This suggests that the conjugation process improves the immune response.\",\n\"answer_choice\": \"C\"\n}"]